NCBiotech Company Directory

A comprehensive listing of North Carolina's life science industry

Mapping large numbers of results may take a few moments.

Search Results

Showing 1 - 24 of 24 results found.

Activity Company Description Location
Company StrideBio Inc. Activity: Research and Development Research and Development Company Description StrideBio develops engineered viral vectors for gene therapy for the treatment of rare diseases. StrideBio's technology engine utilizes structure-inspired design to engineer AAV vectors which can escape pre-existing neutralizing antibodies (NAbs). Location Research Triangle Park
Company Adrenas Therapeutics Inc. Activity: Research and Development Research and Development Company Description Adrenas Therapeutics, a Bridge Bio subsidiary, is developing a gene therapy for the treatment of a monogenic disease that presents in childhood. Location Raleigh
Company AskBio Activity: Research and Development Research and Development Company Description Asklepios BioPharmaceutical (AskBio) uses adeno-associated virus (AAV) technology to develop and manufacture gene therapies for rare diseases and other genetic disorders. Location Research Triangle Park
Company Atsena Therapeutics Inc. Activity: Research and Development Research and Development Company Description Atsena Therapeutics is developing ocular gene therapies to reverse or prevent blindness. Location Durham
Company Bedrock Therapeutics Inc. Activity: Research and Development Research and Development Company Description Bedrock Therapeutics is an AAV research and development company developing platform technologies and therapeutics. Location Raleigh
Company CasTag Biosciences Inc. Activity: Production and Manufacturing Production and Manufacturing Company Description CasTag Biosciences provides custom AAV kits. It uses CRISPR-knock in technology to produce genome-wide arrayed libraries with a variety of donors for endogenous protein analysis in cells and tissue. Location Durham
Company CLAIRIgen Activity: Research and Development Research and Development Company Description CLAIRIgen develops viral vector platforms for gene therapy products to treat central nervous system diseases and conditions. Location Durham
Company Enzerna Biosciences Inc. Activity: Research and Development Research and Development Company Description Enzerna Biosciences is a pre-clinical stage company that is leveraging its proprietary RNA editing technology to develop long-term curative gene therapies for rare genetic disorders such as Huntington's Disease and Myotonic Dystrophy. Location Chapel Hill
Company Epigenos Biosciences Inc. Activity: Research and Development Research and Development Company Description Epigenos Biosciences develops personalized epigenome-based therapeutics that leverage Cas9 technology to treat disease at the root of gene mis-regulation. Location Chapel Hill
Company General Biosystems Inc. Activity: Contract Research and Testing Contract Research and Testing Company Description General Biosystems provides gene synthesis, molecular biology, and protein expression and purification services. Location Durham
Company GeneVentiv Therapeutics Inc. Activity: Research and Development Research and Development Company Description GeneVentiv Therapeutics is a gene therapy company developing a cure for Hemophilia A, Hemophilia B or Factor VIII deficiency, with or without inhibitors. Location Raleigh
Company GENEWIZ Inc. Activity: Contract Research and Testing Contract Research and Testing Company Description Genewiz provides custom DNA sequencing, gene synthesis, genomics, next-generation sequencing and molecular biology in a GLP/cGMP regulatory environment. Location Research Triangle Park
Company Inceptor Bio LLC Activity: Research and Development Research and Development Company Description Inceptor Bio develops next-generation cell therapy platforms, across multiple cell types, to cure cancers. Its site includes a manufacturing facility for production of its therapies. Location Raleigh
Company Isolere Bio Inc. Activity: Research and Development Research and Development Company Description Isolere Bio is developing novel, non-chromatographic technologies for the purification of biologics such as antibodies, gene delivery vectors and personalized cell therapies. Location Durham
Company Jaguar Gene Therapy LLC Activity: Research and Development Research and Development Company Description Jaguar Gene Therapy develops gene therapies for patients suffering from severe genetic diseases. Location Cary
Company Kitty Hawk Biosciences Inc. Activity: Research and Development Research and Development Company Description Kitty Hawk Biosciences is developing enabling technologies for difficult-to-transfect cells to reduce the cost and complexity of ex-vivo cell manipulations for applications in research and clinical settings. Location Cary
Company Kriya Therapeutics Inc. Activity: Production and Manufacturing Production and Manufacturing Company Description Kriya Therapeutics develops AAV-based gene therapies for the treatment of type 1 and type 2 diabetes, severe obesity, and other indications. This location is the company's internal manufacturing facility. Location Morrisville
Company Novartis Gene Therapies Activity: Production and Manufacturing Production and Manufacturing Company Description Novartis Gene Therapies develops and commercializes gene therapy products for neurological genetic diseases. The Durham site is Novartis Gene Therapies' manufacturing operations. Location Durham
Company OncoTrap Inc. Activity: Research and Development Research and Development Company Description OncoTrap is developing a nucleic acid delivery platform for accommodating nucleic acid-based therapeutics, designed to deliver therapeutic genes to tumor sites. Location Research Triangle Park
Company Pfizer Inc. (Chapel Hill) Activity: Research and Development Research and Development Company Description Pfizer's Bamboo Therapeutics develops gene therapies to treat rare genetic central nervous system (CNS) and neuromuscular diseases, including Giant Axonal Neuropathy (GAN), Canavan Disease, Friedreich's Ataxia and Duchenne Muscular Dystrophy (DMD). Location Chapel Hill
Company RainBio Inc. Activity: Research and Development Research and Development Company Description RainBio is developing AAV (adeno-associated virus) gene therapy corneal treatments to address the unmet need of treatment of rare corneal blinding diseases. Location Raleigh
Company Resilience Activity: Production and Manufacturing Production and Manufacturing Company Description National Resilience manufactures lentiviral vectors, a component of cell and gene therapies. Location Durham
Company SNP Therapeutics LLC Activity: Research and Development Research and Development Company Description SNP Therapeutics develops genetic tests to identify genetic variants that contribute to disease. SNP also designs medical nutrition to treat metabolic disorders. Location Kannapolis
Company ViraSource LLC Activity: Contract Research and Testing Contract Research and Testing Company Description ViraSource propagates and purifies BSL-1, BSL-2 viruses and bacteriophages. ViraSource also provides virus modifications and animal models of viral infections and antiviral immune responses. Location Durham